Prognostic value of DNA ploidy and nuclear morphometry in prostate cancer treated with androgen deprivation
✍ Scribed by José M Martı́nez-Jabaloyas; José L Ruiz-Cerdá; Miguel Hernández; Ana Jiménez; Fernando Jiménez-Cruz
- Book ID
- 117264307
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 118 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The prognostic significance of primary tumor dna-ploidy and s-phase fraction (spf) was evaluated in patients treated with androgen ablation for regionally localized node-positive prostate cancer. ## Methods: All patients were diagnosed with lymph node involvement by pelvic lymphade
## Abstract Androgen‐deprivation therapy (ADT) is the most common therapy for advanced prostate cancer, but the prognosis significantly differs among individuals. In this study, we evaluated recently identified 19 prostate cancer susceptibility variants as prognostic predictors for the survival aft